NM_001162529.3(FAM135A):c.2648A>G (p.Asp883Gly) AND not specified

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Feb 21, 2024
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV004378661.1

Allele description [Variation Report for NM_001162529.3(FAM135A):c.2648A>G (p.Asp883Gly)]

NM_001162529.3(FAM135A):c.2648A>G (p.Asp883Gly)

Gene:

FAM135A:family with sequence similarity 135 member A [Gene - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

6q13

Genomic location:

Preferred name:

NM_001162529.3(FAM135A):c.2648A>G (p.Asp883Gly)

HGVS:

NC_000006.12:g.70525732A>G
NG_054903.1:g.117329A>G
NM_001105531.3:c.2060A>G
NM_001162529.3:c.2648A>GMANE SELECT
NM_001330995.3:c.1520-132A>G
NM_001330996.3:c.2726A>G
NM_001330997.3:c.2060A>G
NM_001330998.3:c.2138A>G
NM_001330999.3:c.2726A>G
NM_001331000.3:c.1961A>G
NM_001331001.3:c.2060A>G
NM_001331002.3:c.2060A>G
NM_001331003.3:c.2138A>G
NM_001331004.3:c.1373A>G
NM_001331005.3:c.2549A>G
NM_001331006.3:c.1598-132A>G
NM_001351599.2:c.2726A>G
NM_001351600.2:c.2648A>G
NM_001351602.2:c.2648A>G
NM_001351607.2:c.2648A>G
NM_001351608.2:c.1802A>G
NM_001351609.2:c.1340-132A>G
NM_020819.5:c.2009A>G
NP_001099001.1:p.Asp687Gly
NP_001156001.1:p.Asp883Gly
NP_001317925.1:p.Asp909Gly
NP_001317926.1:p.Asp687Gly
NP_001317927.1:p.Asp713Gly
NP_001317928.1:p.Asp909Gly
NP_001317929.1:p.Asp654Gly
NP_001317930.1:p.Asp687Gly
NP_001317931.1:p.Asp687Gly
NP_001317932.1:p.Asp713Gly
NP_001317933.1:p.Asp458Gly
NP_001317934.1:p.Asp850Gly
NP_001338528.1:p.Asp909Gly
NP_001338529.1:p.Asp883Gly
NP_001338531.1:p.Asp883Gly
NP_001338536.1:p.Asp883Gly
NP_001338537.1:p.Asp601Gly
NP_065870.3:p.Asp670Gly
NC_000006.11:g.71235435A>G
NM_001162529.1:c.2648A>G

Protein change:

D458G

Molecular consequence:

NM_001330995.3:c.1520-132A>G - intron variant - [Sequence Ontology: SO:0001627]
NM_001331006.3:c.1598-132A>G - intron variant - [Sequence Ontology: SO:0001627]
NM_001351609.2:c.1340-132A>G - intron variant - [Sequence Ontology: SO:0001627]
NM_001105531.3:c.2060A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001162529.3:c.2648A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001330996.3:c.2726A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001330997.3:c.2060A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001330998.3:c.2138A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001330999.3:c.2726A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001331000.3:c.1961A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001331001.3:c.2060A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001331002.3:c.2060A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001331003.3:c.2138A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001331004.3:c.1373A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001331005.3:c.2549A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001351599.2:c.2726A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001351600.2:c.2648A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001351602.2:c.2648A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001351607.2:c.2648A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001351608.2:c.1802A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_020819.5:c.2009A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:: AllHighlyPenetrant
Identifiers:: MedGen: CN169374

Recent activity

Clear Turn Off Turn On

PREDICTED: Rattus norvegicus BRCA1, DNA repair associated (Brca1), transcript va...
PREDICTED: Rattus norvegicus BRCA1, DNA repair associated (Brca1), transcript variant X1, mRNA
gi|2678880585|ref|XM_008768092.4|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV004865027	Ambry Genetics	criteria provided, single submitter (Ambry Variant Classification Scheme 2023)	Uncertain significance (Feb 21, 2024)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV004865027

Ambry Genetics

criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)

Uncertain significance
(Feb 21, 2024)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Ambry Genetics, SCV004865027.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

The c.2648A>G (p.D883G) alteration is located in exon 13 (coding exon 12) of the FAM135A gene. This alteration results from a A to G substitution at nucleotide position 2648, causing the aspartic acid (D) at amino acid position 883 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: May 7, 2024

ClinVar

Relating variation to medicine